Economic Paper

Describe the business and explain the general pattern of change of the particular market

model indicating how this change is likely to impact business operations.

GlaxoSmithKline (GSK) is among the top 20 Global 500 companies and among the top five pharmaceutical companies in the world. GSK develops, manufactures and markets pharmaceuticals, vaccines, over-the-counter (OTC) medicines, and health-related consumer products (Datamonitor, 2005). The company primarily operates in 116 countries and its marketing is done in over 125 countries. The companies headquarters is in Brentford, UK and employs about 100,000 people (GSK, 2004).

GSK is the third largest pharmaceutical company in the world, and started operations on January1, 2001 through mergers and acquisitions started by John K. Smith. The merger consists of GlaxoWellcome and SmithKline Beecham, GlaxoSmithKline is a global healthcare company that researches and develops innovative medicines and brands.

Glaxo SmithKline dates back to 1859 when SmithKline Beecham opened the world’s first factory built for medicines in England. SmithKline has served communities for over 150 years which markets pharmaceutical, vaccines, and over the counter medicine (Datamonitor, 2005). Since the merge of SmithKline Beecham and Glaxo Wellcome, Glaxo SmithKline conquered many obstacles through the impact of cultures, structure, stakeholders, and strategies due to this merger. GSK provides products that are used all over the world by millions of people. The company’s goal is to provide the clients with a product to keep them healthy and living longer. GSK has three primary areas of business which are pharmaceuticals, vaccines and consumer health care to get people healthy and help them live longer.

When two or more companies decide to merge, the structure always changes. The change was announced which influenced the culture at the departments which was Research and Development (R&D) and the Civil Engineering Department....